Business Context and Reporting Period
This Form 8-K is a current report filed by Aimei Health Technology Co., Ltd. on June 24, 2026, with events reported through June 29, 2026. The company is incorporated in the Cayman Islands and its ordinary shares trade on The Nasdaq Stock Market LLC under the symbol AFJK. The filing addresses changes to the Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
- Director Resignation: Ms. Julianne Huh resigned as a director effective June 24, 2026. The resignation was due to personal reasons and was not the result of any disagreement with the Company regarding operations, policies, or practices.
- Director Appointment: On June 29, 2026, the Board appointed Mr. Daniel Veikko Polvi as a new director. Mr. Polvi is the managing director of Shearwater Limited, a management consulting firm, and holds an MBA from BI Norwegian Business School.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future business performance. No material risks, contingencies, or unusual items were disclosed in this report. The Company confirmed that Ms. Huh has been paid all amounts due and has released the Company from all claims.
Key Facts for Investor Verification
- Verify the effective date of Ms. Julianne Huh's resignation (June 24, 2026) and the appointment of Mr. Daniel Veikko Polvi (June 29, 2026).
- Confirm that the resignation was explicitly stated as being for personal reasons with no disagreement on company matters.
- Review Mr. Polvi's background in business management and consulting to assess his qualifications for the Board.
- Note that this filing does not impact the Company's financial statements or operational metrics.